Stocks Health care GMED
NYSE · Health careGlobus Medical Inc (GMED)
Globus Medical Inc brought in $3.1B of revenue over the twelve months to September 30, 2026, up 13.4% from a year earlier. Net income was $557.6M, a net margin of 17.8%. Operating cash flow minus capital spending left $588.8M of free cash flow in fiscal 2025. At September 30, 2026 it held $441.3M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Globus Medical Inc
- Net worth
- Globus Medical Inc has a market value (market cap) of $10.1B at the latest share price, and shareholders' equity of $4.8B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $2.9B (+16.7% year on year), with net income of $537.9M. Over the 12 months to September 30, 2026: revenue $3.1B, net income $557.6M.
- Cash flow
- In fiscal 2025 operations brought in $753.4M of cash; after $164.7M of capital spending, free cash flow was $588.8M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Globus Medical Inc's next report is expected around January 6, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Globus Medical Inc does
Globus Medical Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker GMED.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $2.9B | $537.9M | $3.92 | $588.8M |
| 2024 | $2.5B | $103M | $0.75 | $405.2M |
| 2023 | $1.6B | $122.9M | $1.07 | $165.2M |
| 2022 | $1B | $190.2M | $1.85 | $104.4M |
| 2021 | $958.1M | $149.2M | $1.44 | $219.4M |
| 2020 | $789M | $102.3M | $1.01 | $135.1M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where GMED ranks in Health care
Latest SEC filings
What Globus Medical Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue fell 0.7% to $763.7M versus the same quarter last year; diluted EPS $1.04 versus $0.88.
- November 5, 2026
- October 30, 2026Passive stake changed SCHEDULE 13G/A
- October 27, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 5.9% to $789.6M versus the same quarter last year; diluted EPS $1.10 versus $1.49.
- August 6, 2026
- June 4, 2026
- May 27, 2026
- May 7, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 27% to $759.9M versus the same quarter last year; diluted EPS $0.90 versus $0.54.
- May 7, 2026
What is GMED worth? A DCF from its reported cash flow
Insider trades
What the people running Globus Medical Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $4.8M worth of shares in the last 90 days and bought none on the open market. 9% of the selling was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| November 4, 2026 | Rhoads Ann DDirector | Soldpre-planned (10b5-1) | 5,000 | $425K |
| September 15, 2026 | Tobin James RDirector | Exercised options | 15,000 | $806.3K |
| September 15, 2026 | Tobin James RDirector | Exercised options | 15,000 | $955.2K |
| September 15, 2026 | Tobin James RDirector | Sold | 30,000 | $2.2M |
| August 18, 2026 | Zarrilli Stephen TDirector | Exercised options | 25,000 | $1.3M |
| August 18, 2026 | Zarrilli Stephen TDirector | Sold | 25,000 | $2.2M |
| July 27, 2026 | Davidar David DDirector | Gave as a gift | 2,500 | - |
| June 5, 2026 | Davidar David DDirector | Exercised options | 25,000 | $656.8K |
Who owns GMED
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| BlackRock, Inc.13G, passive | 8% | October 27, 2026 |
| Janus Henderson Group PLC13G, passive | 6.1% | May 14, 2025 |
| Vanguard Capital Management13G, passive | 5.22% | April 30, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 597 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 10,806,724 | +309,310 |
| Jupiter Topco LLC | 8,200,423 | new |
| Vanguard Capital Management LLC | 5,107,532 | +74,800 |
| Vanguard Portfolio Management LLC | 4,994,385 | +114,926 |
| Invesco Ltd. | 4,309,771 | -6,883 |
| Kayne Anderson Rudnick Investment Management LLC | 4,279,730 | new |
| State Street Corp | 3,714,029 | +123,657 |
| Sculptor Capital LP | 3,000,000 | -58,000 |
| Jpmorgan Chase & Co | 2,743,850 | +148,542 |
| Alliancebernstein L.P. | 2,380,344 | +629,512 |
| Bank of Montreal | 2,425,491 | +118,310 |
| Dimensional Fund Advisors LP | 2,369,310 | +599,413 |
| Geode Capital Management, LLC | 2,153,014 | +40,890 |
| Goldman Sachs Group Inc | 1,781,608 | +649,446 |
| Arrowstreet Capital, Limited Partnership | 1,716,621 | +803,716 |
| Boston Trust Walden Corp | 1,573,361 | +318,451 |
| Boston Partners | 1,554,990 | new |
| Allspring Global Investments Holdings, LLC | 1,571,681 | +1,143,641 |
| Geneva Capital Management LLC | 1,417,067 | -343,904 |
| William Blair Investment Management, LLC | 1,284,896 | -724,867 |
Insiders
4 insiders reported holding 613,895 shares in total, about $46.1M at the last price.
| Holder | Shares |
|---|---|
| Davidar David DDirector | 507,675 |
| Paul David CExecutive Chairman, Director, 10% owner | 60,417 |
| Rhoads Ann DDirector | 35,384 |
| Norwalk Leslie VDirector | 10,419 |
Questions about GMED
What does Globus Medical Inc do?
Globus Medical Inc is a company in the Health care sector, listed on NYSE as GMED. Its shares trade on NYSE under the ticker GMED.
What is Globus Medical Inc's net worth?
Globus Medical Inc has a market value (market cap) of $10.1B at the latest share price, and shareholders' equity of $4.8B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Globus Medical Inc profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $557.6M on revenue of $3.1B, a net margin of 17.8%.
How much revenue does Globus Medical Inc make?
Over the twelve months to September 30, 2026 Globus Medical Inc reported revenue of $3.1B. That is 13.4% more than a year earlier.
When did Globus Medical Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.
When is Globus Medical Inc's next earnings report?
Globus Medical Inc's next report is expected around January 6, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare GMED with
Follow GMED
Get an email when Globus Medical Inc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Globus Medical Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.